advertisement

---

14 Costing studies; pharmacoeconomics (18)

Showing records 1 to 18

Display all abstracts in classification 14 Costing studies; pharmacoeconomics

Search within classification 14 Costing studies; pharmacoeconomics

---

94503 Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana
Ofei-Palm CNK
ClinicoEconomics and outcomes research : CEOR 2021; 13: 619-627

---

94810 Impact of discontinuing government-funded routine eye exams on new glaucoma diagnoses in Ontario
Jin YP
Canadian Journal of Ophthalmology 2022; 57: 319-327

---

95048 A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
Nieland K; Labbé A
PLoS ONE 2021; 16: e0252130

---

94503 Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana
Tagoe NN
ClinicoEconomics and outcomes research : CEOR 2021; 13: 619-627

---

94810 Impact of discontinuing government-funded routine eye exams on new glaucoma diagnoses in Ontario
Buys YM
Canadian Journal of Ophthalmology 2022; 57: 319-327

---

95048 A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
Schweitzer C
PLoS ONE 2021; 16: e0252130

---

94503 Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana
Jatoe D
ClinicoEconomics and outcomes research : CEOR 2021; 13: 619-627

---

94810 Impact of discontinuing government-funded routine eye exams on new glaucoma diagnoses in Ontario
Vujicic M; El-Defrawy S
Canadian Journal of Ophthalmology 2022; 57: 319-327

---

94503 Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana
Agyare A
ClinicoEconomics and outcomes research : CEOR 2021; 13: 619-627

---

95048 A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
Gicquel G
PLoS ONE 2021; 16: e0252130

---

94810 Impact of discontinuing government-funded routine eye exams on new glaucoma diagnoses in Ontario
El-Defrawy S
Canadian Journal of Ophthalmology 2022; 57: 319-327

---

95048 A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
Kleintjens J
PLoS ONE 2021; 16: e0252130

---

94810 Impact of discontinuing government-funded routine eye exams on new glaucoma diagnoses in Ontario
Brent MH
Canadian Journal of Ophthalmology 2022; 57: 319-327

---

94503 Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana
Ankrah D
ClinicoEconomics and outcomes research : CEOR 2021; 13: 619-627

---

94810 Impact of discontinuing government-funded routine eye exams on new glaucoma diagnoses in Ontario
Jeon W
Canadian Journal of Ophthalmology 2022; 57: 319-327

---

95048 A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
Ostawal A; Treur M
PLoS ONE 2021; 16: e0252130

---

94810 Impact of discontinuing government-funded routine eye exams on new glaucoma diagnoses in Ontario
Trope GE
Canadian Journal of Ophthalmology 2022; 57: 319-327

---

95048 A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France
Falvey H
PLoS ONE 2021; 16: e0252130

---

---